Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer

An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases

(2012) Liang Zeng et al.   SUPPORTIVE CARE IN CANCER

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

(2011) J. Maringwa et al.   ANNALS OF ONCOLOGY

Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma

(2011) Ann Kristin Kvam et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy

(2011) Amanda Caissie et al.   SUPPORTIVE CARE IN CANCER

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

(2010) John T. Maringwa et al.   SUPPORTIVE CARE IN CANCER

The EORTC quality of life questionnaire QLO-C30 (version 3.0): Validation study for spanish prostate cancer patients

(2010) Juan Ignacio Arraras Urdaniz et al.   ARCHIVOS ESPANOLES DE UROLOGIA

What changes in health-related quality of life matter to multiple myeloma patients? A prospective study

(2009) Ann K. Kvam et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index

(2009) Amanda Hird et al.   SUPPORTIVE CARE IN CANCER

Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery

(2008) Susanne Singer et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

(2008) David Cella et al.   VALUE IN HEALTH

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY